Sign in
4

Changes in Ownership

Perspective Therapeutics, Inc. Filed Acc 0001642247-17-000009

Options or other derivatives

  • CEO acquired 715,000 shares (grant or award)
  • CEO returned 350,000 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

LAVOY THOMAS C · CEO

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2017-06-15 Returned to the company : show line 1 in the form Stock Options (right to buy) −250,000 0 D
2017-06-15 Returned to the company : show line 2 in the form Stock Options (right to buy) −100,000 0 D
2017-06-27 Grant or award : show line 3 in the form Stock Options (right to buy) +715,000 0 D
Loading xslF345X03/primary_doc.xml…